Status:
NOT_YET_RECRUITING
The Application of Rapid Fresh Digital Pathology on the Diagnosis and Biomarker Testing of Lung Cancer
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Lung Cancer
Intraoperative Pathology
Eligibility:
All Genders
20+ years
Brief Summary
Through this project, the rapid staining process will be optimized for ex-vivo human lung specimens and integrate advanced ex-vivo mesoscale nonlinear optical gigascope. Initially, this will provide r...
Detailed Description
Frozen section can provide rapid diagnosis during the operation, and its information is very important for surgeons to make decisions for the operative methods, especially for patients whose clinical ...
Eligibility Criteria
Inclusion
- (1) Adults aged 20 and above.
- (2) Patients diagnosed with lung cancer or lung tumors, scheduled for surgical resection.
- A total of 300 patients are expected to be included.
Exclusion
- (1) Patients unable to provide consent. (e.g., inability to speak, inability to communicate in Chinese, etc.).
- (2) Patients for whom a definitive pathological diagnosis cannot be established.
- (3) Patients suitable only for biopsy and not for surgical resection.
- (4) Exclude specimens that are too small or lesions that are too small to retain extra tissue.
Key Trial Info
Start Date :
July 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06497686
Start Date
July 15 2024
End Date
December 31 2025
Last Update
July 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.